Previous 10 | Next 10 |
Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies , announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders is ...
Webinar to be held Wednesday, April 19, 2023 at 12:00 pm ET / 6:00 pm CET Regulatory News: TRANSGENE (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that it will host a virtual Key Opinion Leader (KOL)...
2023-04-03 16:41:21 ET Summary Merger arbitrage spreads are wide. There are plenty of opportunities with spreads of up to 118%. This is a review of the most interesting transactions in the merger arbitrage space. Merger arbitrage is an event-driven investment strategy of...
TEGNA Inc. (NYSE: TGNA) announced today that WKYC in Cleveland and WXIA in Atlanta have received three 2023 Gracie Awards from the Alliance for Women in Media Foundation. The Gracie Awards shine a spotlight on women in media and recognize individuals who have made inspirational contributions to t...
2023-03-28 09:29:45 ET Standard General has headed to court to help salvage a struggling $5.4B deal for Tegna ( NYSE: TGNA ), filing suit against the Federal Communications Commission to try to surpass a "pocket veto" of the transaction. The FCC said a month ago that it woul...
Regulatory News: TRANSGENE (Paris: TNG) , a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that Management will participate in several investor events, as set out below. The Future of Oncology Symposium , ...
Positive data on key clinical candidates delivered in 2022 – Promising outlook for 2023 as industry interest in therapeutic cancer vaccines and oncolytic viruses gains significant momentum - TG4050: New Phase I data confirm the strong clinical and commercial potential o...
TEGNA Inc. (NYSE: TGNA) today announced that Tim Thomas has been appointed president and general manager at WTLV and WJXX, the NBC and ABC affiliates in Jacksonville, effective April 3, 2023. Thomas will be responsible for overseeing the stations’ operations across platforms, as well as le...
Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces the appointment of Dr. John C. Bell and Dr. Pedro Romero as key scientific advisors. “John and Pedr...
2023-03-09 01:51:00 ET Summary The U.S. Department of Justice on Tuesday sued to block JetBlue Airways’ $3.8 billion acquisition of Spirit Airlines. It would be the third curious regulatory intervention in recent weeks, each encouraged by Democratic Senator Elizabeth Warren...
News, Short Squeeze, Breakout and More Instantly...
Strasbourg, France, and Lund, Sweden, July 22, 2024, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stock...
Gray Media stations in Anchorage and Juneau will broadcast all locally available Seattle Kraken games, free over-the-air beginning with the 2024-2025 season TEGNA Inc. (NYSE: TGNA), the Seattle Kraken and Gray Media (NYSE: GTN) today announced that Gray’s KAUU in Anchorage and ...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or “the Company”) today announced the appointment of two highly seasoned leaders to its executive team. Catherine Dunleavy will join OLAPLEX as Chief Operating Officer and Chie...